LBF20303PG05

LipidBank Top (トップ)

Fatty acid (脂肪酸)

Glycerolipid (グリセロ脂質)

Sphingolipid (スフィンゴ脂質)

Journals (雑誌一覧)

How to edit (ページの書き方)

Upper classes: LB LBF

IDs and Links
LipidBank	XPR1705
LipidMaps	LMFA03010142
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}
mol	LBF20303PG05

Prostaglandin D3
Structural Information
Systematic Name	9α,15S-Dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid
Common Name	Prostaglandin D3
Symbol
Formula	C20H30O5
Exact Mass	350.20932407
Average Mass	350.4492
SMILES	C(=CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC
Physicochemical Information
Melting Point
Boiling Point
Density
Optical Rotation
Refractive Index
Solubility
Source	PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway. Kulkarni_PS et al.
Chemical Synthesis
Metabolism
Biological Activity	PGD3 has almost same ability to decrease systemic blood pressure in rats and to decrease intraocular pressure in rabbits. Bundy_GL et al. Goh_Y et al. Kulkarni_PS et al. However, it is 3 to 5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.
Genetic Information
Note
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

[hide]Reported Metabolites, References
Biospecies ID Compound Name Reference Comment n.a. LBF20303PG05 See above. Bundy_GL et al. 1983 n.a. LBF20303PG05 See above. Goh_Y et al. 1988 n.a. LBF20303PG05 See above. Herschman_HR 1996 n.a. LBF20303PG05 See above. Kulkarni_PS et al. 1987 n.a. LBF20303PG05 See above. Kulkarni_PS et al. 1985 n.a. LBF20303PG05 See above. Smith_WL et al. 1996